Cellular immune correlates of protection against symptomatic pandemic influenza

The role of T cells in mediating heterosubtypic protection against natural influenza illness in humans is uncertain. The 2009 H1N1 pandemic (pH1N1) provided a unique natural experiment to determine whether crossreactive cellular immunity limits symptomatic illness in antibody-naive individuals. We followed 342 healthy adults through the UK pandemic waves and correlated the responses of pre-existing T cells to the pH1N1 virus and conserved core protein epitopes with clinical outcomes after incident pH1N1 infection. Higher frequencies of pre-existing T cells to conserved CD8 epitopes were found in individuals who developed less severe illness, with total symptom score having the strongest inverse correlation with the frequency of interferon-γ (IFN-γ)+ interleukin-2 (IL-2)− CD8+ T cells (r = −0.6, P = 0.004). Within this functional CD8+IFN-γ+IL-2− population, cells with the CD45RA+ chemokine (C-C) receptor 7 (CCR7)− phenotype inversely correlated with symptom score and had lung-homing and cytotoxic potential. In the absence of crossreactive neutralizing antibodies, CD8+ T cells specific to conserved viral epitopes correlated with crossprotection against symptomatic influenza. This protective immune correlate could guide universal influenza vaccine development.

[1]  G. Rimmelzwaan,et al.  Yearly influenza vaccinations: a double-edged sword? , 2009, The Lancet. Infectious diseases.

[2]  K G Moons,et al.  Clinical signs and symptoms predicting influenza infection. , 2001, Archives of internal medicine.

[3]  N. Andrews,et al.  Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study , 2010, The Lancet.

[4]  J. Oxford,et al.  Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans , 2012, Nature Medicine.

[5]  G. Ada,et al.  Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus , 1978, Nature.

[6]  T. Kuiken,et al.  Cross-protective immunity against influenza pH1N1 2009 viruses induced by seasonal influenza A (H3N2) virus is mediated by virus-specific T-cells. , 2011, The Journal of general virology.

[7]  A. McMichael,et al.  Rapid Effector Function in CD8+ Memory T Cells , 1997, The Journal of experimental medicine.

[8]  A. McMichael,et al.  HLA restriction of cell-mediated lysis of influenza virus-infected human cells , 1977, Nature.

[9]  S. An,et al.  The effect of a previous attack of A1 influenza on susceptibility to A2 virus during the 1957 outbreak. , 1959, Bulletin of the World Health Organization.

[10]  C. Tiemessen,et al.  Marked differences in CCR5 expression and activation levels in two South African populations , 2012, Immunology.

[11]  J. Skehel,et al.  Cytotoxic T cells kill influenza virus infected cells but do not distinguish between serologically distinct type A viruses , 1977, Nature.

[12]  S. Epstein.  Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature. , 2006, The Journal of infectious diseases.

[13]  N. Ferguson,et al.  Closure of schools during an influenza pandemic , 2009, The Lancet Infectious Diseases.

[14]  W. Luttmann,et al.  Differential expression of human granzymes A, B, and K in natural killer cells and during CD8+ T cell differentiation in peripheral blood , 2005, European journal of immunology.

[15]  B. Askonas,et al.  Influenza nucleoprotein-specific cytotoxic T-cell clones are protective in vivo. , 1986, Immunology.

[16]  B. Cowling,et al.  Validation of Self-swab for Virologic Confirmation of Influenza Virus Infections in a Community Setting , 2011, The Journal of infectious diseases.

[17]  David L. Woodland,et al.  The chemokine receptor CCR5 plays a key role in the early memory CD8+ T cell response to respiratory virus infections. , 2008, Immunity.

[18]  O. Keene,et al.  Diagnosis of influenza in the community: relationship of clinical diagnosis to confirmed virological, serologic, or molecular detection of influenza. , 2001, Archives of internal medicine.

[19]  A. Osterhaus,et al.  Characterization of the Human CD8+ T Cell Response following Infection with 2009 Pandemic Influenza H1N1 Virus , 2011, Journal of Virology.

[20]  A. Osterhaus,et al.  Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus. , 2009, Vaccine.

[21]  A. Kelso,et al.  Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses , 2010, Proceedings of the National Academy of Sciences.

[22]  M. Kiso,et al.  Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses , 2010, Proceedings of the National Academy of Sciences.

[23]  Benjamin J. Cowling,et al.  Epidemiological Characteristics of 2009 (H1N1) Pandemic Influenza Based on Paired Sera from a Longitudinal Community Cohort Study , 2011, PLoS medicine.

[24]  A. McMichael,et al.  Recognition of the PB1, neuraminidase, and matrix proteins of influenza virus A/NT/60/68 by cytotoxic T lymphocytes. , 1989, Virology.

[25]  A. Osterhaus,et al.  Human T-cells directed to seasonal influenza A virus cross-react with 2009 pandemic influenza A (H1N1) and swine-origin triple-reassortant H3N2 influenza viruses. , 2013, The Journal of general virology.

[26]  T. Kuiken,et al.  Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice. , 2007, Vaccine.

[27]  Y. Guan,et al.  H 5 N 1 influenza : A protean pandemic threat , 2005 .

[28]  F. Hayden,et al.  Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. , 1998, The Journal of clinical investigation.

[29]  Y. Guan,et al.  Cytotoxic T Lymphocytes Established by Seasonal Human Influenza Cross-React against 2009 Pandemic H1N1 Influenza Virus , 2010, Journal of Virology.

[30]  R. Couch,et al.  Induction of partial immunity to influenza by a neuraminidase-specific vaccine. , 1974, The Journal of infectious diseases.

[31]  R. V. van Lier,et al.  Selective accumulation of differentiated CD8+ T cells specific for respiratory viruses in the human lung , 2005, The Journal of experimental medicine.

[32]  E. D. Kilbourne,et al.  Induction of Partial Specific Heterotypic Immunity in Mice by a Single Infection with Influenza A Virus , 1965, Journal of bacteriology.

[33]  R. Webster,et al.  H5N1 influenza: a protean pandemic threat. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. Zambon,et al.  Confronting the avian influenza threat: vaccine development for a potential pandemic , 2004, The Lancet Infectious Diseases.

[35]  Gabriele Neumann,et al.  Human infection with highly pathogenic H5N1 influenza virus , 2008, The Lancet.

[36]  A. Osterhaus,et al.  Annual Vaccination against Influenza Virus Hampers Development of Virus-Specific CD8+ T Cell Immunity in Children , 2011, Journal of Virology.

[37]  A. Monto,et al.  The Tecumseh study of respiratory illness. VII. Further observations on the occurrence of respiratory syncytial virus and Mycoplasma pneumoniae infections. , 1971, American journal of epidemiology.

[38]  A. Bermingham,et al.  Predominance of heterosubtypic IFN‐γ‐only‐secreting effector memory T cells in pandemic H1N1 naive adults , 2012, European journal of immunology.

[39]  Bjoern Peters,et al.  Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population , 2009, Proceedings of the National Academy of Sciences.

[40]  Nicholas S. Kelley,et al.  Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. , 2012, The Lancet. Infectious diseases.

[41]  B. Moss,et al.  Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[42]  W. Carman,et al.  During the summer 2009 outbreak of "swine flu" in Scotland what respiratory pathogens were diagnosed as H1N1/2009? , 2011, BMC infectious diseases.

[43]  R. Koup,et al.  Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. , 2003, Journal of immunological methods.

[44]  J. M. Grant.  'An experiment in nature'. , 1978, Archives of dermatology.

[45]  K. Broman,et al.  Cross-Reactive T Cells Are Involved in Rapid Clearance of 2009 Pandemic H1N1 Influenza Virus in Nonhuman Primates , 2011, PLoS pathogens.

[46]  Anand Kumar,et al.  Chemokine Receptor 5 Δ32 Allele in Patients with Severe Pandemic (H1N1) 2009 , 2010, Emerging infectious diseases.

[47]  Paul Kellam,et al.  IFITM3 restricts the morbidity and mortality associated with influenza , 2012, Nature.

[48]  Kristin M. Scheible,et al.  CD8+ T cell immunity to 2009 pandemic and seasonal H1N1 influenza viruses. , 2011, Vaccine.

[49]  J. Rothbard,et al.  Recognition of influenza virus proteins by cytotoxic T lymphocytes. , 1989, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[50]  A. Monto,et al.  The Tecumseh Study of Respiratory Illness. IX. Occurence of influenza in the community, 1966--1971. , 1975, American journal of epidemiology.

[51]  K. Laurie,et al.  Cross-Reactive Influenza-Specific Antibody-Dependent Cellular Cytotoxicity Antibodies in the Absence of Neutralizing Antibodies , 2013, The Journal of Immunology.

[52]  A. Osterhaus,et al.  Cross-Recognition of Avian H5N1 Influenza Virus by Human Cytotoxic T-Lymphocyte Populations Directed to Human Influenza A Virus , 2008, Journal of Virology.

[53]  Benjamin Schwartz,et al.  Superiority of reverse-transcription polymerase chain reaction to conventional viral culture in the diagnosis of acute respiratory tract infections in children. , 2004, The Journal of infectious diseases.

[54]  A. McMichael,et al.  Cytotoxic T-cell immunity to influenza. , 1983, The New England journal of medicine.

[55]  P. Moss,et al.  Selective accumulation of virus-specific CD8+ T cells with unique homing phenotype within the human bone marrow. , 2008, Blood.

[56]  Ajit Lalvani,et al.  Enumeration of Functional T-Cell Subsets by Fluorescence-Immunospot Defines Signatures of Pathogen Burden in Tuberculosis , 2010, PloS one.

[57]  J. Farrar,et al.  Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. , 2008, The Journal of clinical investigation.

[58]  Antonio Lanzavecchia,et al.  Central memory and effector memory T cell subsets: function, generation, and maintenance. , 2004, Annual review of immunology.